Pasithea Therapeutics Corp. Share Price
KTTAPasithea Therapeutics Corp. Stock Performance
Open $0.89 | Prev. Close $0.89 | Circuit Range N/A |
Day Range $0.88 - $0.89 | Year Range $0.29 - $3.85 | Volume 2,058 |
Average Traded $0.89 |
Pasithea Therapeutics Corp. Share Price Chart
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
13-Jan-26 | $0.89 | $0.88 | +0.00% |
13-Jan-26 | $0.89 | $0.88 | -3.41% |
12-Jan-26 | $0.91 | $0.91 | -2.05% |
08-Jan-26 | $0.93 | $0.93 | -1.38% |
07-Jan-26 | $1.07 | $0.94 | -14.84% |
06-Jan-26 | $1.11 | $1.10 | -0.45% |
05-Jan-26 | $1.11 | $1.11 | -7.50% |
FAQs on Pasithea Therapeutics Corp. Share Price
Can I buy Pasithea Therapeutics Corp. shares in India?
What is the share price of Pasithea Therapeutics Corp.?
What is the 5 year returns of Pasithea Therapeutics Corp.?
What are the high & low stock price of Pasithea Therapeutics Corp. today?
What is the 52-week high and low of Pasithea Therapeutics Corp. stock?